Author: News Room

Montreal, Quebec, Canada, April 22, 2024 (GLOBE NEWSWIRE) — Climate change is a well-present phenomenon and it affects the entire planet. Just in the last fifty years, within living memory, mass deforestation, carried out willfully by millions of people, has wiped out more than one-fifth of the original Amazon rainforest, the largest tropical rainforest in the world.  In 1975, only 1% of the original forest had been lost to human resource extraction. Today, we have lost almost 20%, leading to species extinction, affecting the world’s weather patterns and contributing to global warming.  […] the film is both visceral and abstract,…

Schneider Electric outlines how software-defined automation is driving industrial growth at Hannover MesseAlongside AVEVA, company unveils latest innovations aimed at boosting industrial productivity, resilience, and efficiencyShowcasing the importance of deep domain expertise, it will demonstrate how its solutions support the entire industrial ecosystem at its #HM24 booth (Hall 11, Stand C52) Schneider Electric, the industrial technology leader of energy management and automation, will showcase the latest innovations in its portfolio, including industrial software, Artificial Intelligence and Digital Twin technology. These solutions will be demonstrated through the lens of a digital and sustainable life science campus, highlighting Schneider’s deep domain expertise…

TORONTO, April 22, 2024 (GLOBE NEWSWIRE) — Aecon Group Inc. (TSX: ARE) (“Aecon” or the “Company”) today released its 2023 Sustainability Report highlighting its progress and role in Advancing the Energy Transition. “Our 2023 Sustainability Report illustrates our role as an innovative partner in delivering projects that will accelerate the energy transition in support of a net-zero future, and our commitment to sustainability in delivering infrastructure that aligns with our purpose – building what matters to enable future generations to thrive,” said Jean-Louis Servranckx, President & Chief Executive Officer, Aecon Group Inc. “We are proud to build and operate infrastructure…

Bedford, TX, April 22, 2024 (GLOBE NEWSWIRE) — Digestive Health Associates of Texas is proud to welcome the addition of Dr. Bhavin Patel, a physician passionate about treating all gastrointestinal diseases while specializing in IBD, esophageal dysphagia, colon cancer screening, GERD, IBS, fecal incontinence, liver disease and nutrition. Dr. Patel is an experienced gastroenterologist affiliated with the American College of Gastroenterology, American Board of Internal Medicine, and many more. He received his doctorate from Windsor University School of Medicine and completed his residency at Richmond University Medical Center. “My patients can expect a patient-centered approach focused on providing personalized care,”…

NORTH ARLINGTON, N.J., April 22, 2024 (GLOBE NEWSWIRE) — Collective Audience, Inc. (Nasdaq: CAUD), a leading innovator of audience-based performance advertising and media solutions, announced its CEO, Peter Bordes, has been inducted into the The New Jersey Ad Club Advertising Hall of Fame in recognition of his many career achievements and their contribution to the industry. He was joined by Edward Burns of New Jersey Advance Media; Michelle Lazzarotti of Saint Peter’s University Hospital; Ken Lombardo of SGW Integrated Marketing; and Tom Sullivan of Princeton Partners. The five new inductees will be honored during a ceremony on June 5, 2024,…

BOSTON and LONDON, April 22, 2024 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug application (IND) to initiate a Phase 1 first-in-human, clinical trial of ORX750 for the treatment of narcolepsy. ORX750 is an investigational, orally administered, highly potent and selective orexin receptor 2 (OX2R) agonist designed to directly target the underlying pathophysiology of orexin neuron loss in narcolepsy type 1 (NT1), with potential applicability to narcolepsy type…

BUCHAREST, Romania, April 22, 2024 (GLOBE NEWSWIRE) — Just two months after the official token launch, TOKERO announced the closure of its first funding round held in Private Sale mode. The price of a $TOKERO LevelUP token was $0.02 USDT/token, and the company’s target of $1.4 million was successfully achieved. Token packages offered for sale ranged from $1,000 to $250,000, from “Shrimp” to “Whale”. “Since our beginnings in 2018, we have been very close to the community, and that’s why we wanted to democratize the Private stage. So far, Angel investors and venture capital (VC) funds typically invest in such…

MENLO PARK, Calif., April 22, 2024 (GLOBE NEWSWIRE) — Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol, today announced positive results from the open-label portion of the pivotal Phase 3 GRACE trial of its proprietary selective cortisol modulator relacorilant in patients with all etiologies of endogenous Cushing’s syndrome (hypercortisolism). GRACE has two parts. In the “open-label” phase, 152 patients with Cushing’s syndrome and either hypertension, hyperglycemia or both received relacorilant for 22 weeks. Patients who…

Nashville, Tenn. (April 22, 2024), April 22, 2024 (GLOBE NEWSWIRE) — Nashville Entrepreneur Center (NEC), a non-profit dedicated to supporting entrepreneurs and local industry, announced the appointment of David Malone as the new Executive-in-Residence for its Project FinTech accelerator. This initiative is designed to propel forward-thinking financial services startups to new heights by providing expert guidance and industry-specific mentorship.David Malone brings to Project FinTech a storied career as a strategic leader and an innovator in the financial services sector. As a co-founder of Confirmation, a pioneering software solutions provider for the financial industry, David played a pivotal role in growing…

New York, April 22, 2024 (GLOBE NEWSWIRE) — Beauty Right, a brand specializing in dietary supplements, introduces GLP-1 Active Peptide Capsules, a nutritional supplement designed to help people achieve their ideal physique through a science-based and healthy approach. Unlocking the Power of GLP-1 in Daily HealthGLP-1 serves a crucial role in regulating blood sugar levels by stimulating the secretion of insulin after meals and inhibiting the release of glucagon. The GLP-1 active peptide capsules are intended for daily use to boost the body’s natural production of GLP-1. By regulating overall metabolism, these capsules help establish healthy eating habits and support…